{
  "Disease": [
    {"role": "system", "content": "You are a knowledgeable assistant specialized in recognizing and understanding named entities and their interrelations. If requested to organize information in tabular format, you are adept at filtering and presenting only the relevant and valid results. You will exclude any results that are not pertinent or are inaccurate from the table according to the discussion history."},
    {"role": "user", "content": "Please identify the \"Disease\" entities in the following paragraph.\n\nParagraph: CIN was significantly more after treatment with bevacizumab / irinotecan ( P = 0 . 021 ) and in patients with hypertension ( P = 0 . 044 ) .\n\nLet's think step by step."},
    {"role": "assistant", "content": "Based on the given paragraph, the identified \"Disease\" entities are:\n\n1. Hypertension"},
    {"role": "user", "content": "Please present the valid entities as a Markdown table with one column \"Disease\".\n\nMake sure to present the entities precisely in the same words as in the original paragraph."},
    {"role": "assistant", "content": "| Disease       |\n|---------------|\n| Hypertension  |"}
  ],
  "Chemical": [
    {"role": "system", "content": "You are a knowledgeable assistant specialized in recognizing and understanding named entities and their interrelations. If requested to organize information in tabular format, you are adept at filtering and presenting only the relevant and valid results. You will exclude any results that are not pertinent or are inaccurate from the table according to the discussion history."},
    {"role": "user", "content": "Please identify the \"Chemical\" entities in the following paragraph.\n\nParagraph: CIN was significantly more after treatment with bevacizumab / irinotecan ( P = 0 . 021 ) and in patients with hypertension ( P = 0 . 044 ) .\n\nLet's think step by step."},
    {"role": "assistant", "content": "Sure! Let's identify the \"Chemical\" entities in the paragraph.\n\n1. bevacizumab: This is a chemical entity. It is a monoclonal antibody that inhibits the growth of new blood vessels.\n\n2. irinotecan: This is also a chemical entity. It is a chemotherapy drug used to treat various types of cancer.\n\nSo, the identified \"Chemical\" entities in the paragraph are bevacizumab and irinotecan."},
    {"role": "user", "content": "Please present the valid entities as a Markdown table with one column \"Chemical\".\n\nMake sure to present the entities precisely in the same words as in the original paragraph."},
    {"role": "assistant", "content": "| Chemical     |\n|--------------|\n| bevacizumab  |\n| irinotecan   |"}
  ]
}